Background
Gray font color on white background Black font color on white background White font color on black background White font color on dark blue background
Font Size
Resources » Glossary
Search This Page 

After you have entered your search term, please hit the enter button on your keyboard.

LCA

see Leber Congenital Amaurosis

Leber Congenital Amaurosis (LCA)

Leber congenital amaurosis (LCA) is an inherited retinal degenerative disease characterized by severe loss of vision at birth. A variety of other eye-related abnormalities including roving eye movements, deep-set eyes, and sensitivity to bright light also occur with this disease. Some patients with LCA also experience central nervous system abnormalities.

Lens

The transparent part of the eye that focuses light onto the retina, so that we can see.

Locus (plural, Loci)

A locus is the chromosomal "neighborhood" where a gene (a "house") resides; specifically, a potential disease-causing gene.

LucentisĀ®

A blood vessel growth-blocking drug approved by the FDA in June 2006 for treatment of wet AMD.

Lutein and Zeaxanthin

Nutrient pigments chemically related to beta-carotene that are abundant in green leafy vegetables and yellow and orange-colored fruits and vegetables. These are the only two known food pigments that collect in the macula, where they are thought to protect it from light damage (blue light).

MacugenĀ®

An anti-VEGF drug approved by the FDA in 2004 for treatment of wet AMD.

Macula

The center of the retina that has a concentration of cone photoreceptor cells and is responsible for fine detail, day and color vision.

Messenger RNA (mRNA)

The processed gene "messenger" (derived from DNA) that is the template for making proteins. Also, see RNA.

Metabolic process

A series of pathways the body uses, both to break down nutrients into simple energy packets and to create building blocks that then build-up cell components and help the body to function.

Mutation

A change or "spelling mistake" in the DNA of a gene that can cause a disease (but sometimes does not cause disease).

NE

see Nutritional and Environmental Therapy

NEI

Acronym for the National Eye Institute, a part of the research-funding government organization, the United States (US) National Institutes of Health.

Neuroprotective Therapy (NP)

Delivering a protein or drug to the eye that prevents the photoreceptors and/or RPE cells from dying, thus saving vision.

NP

see Neuroprotective Therapy

Nucleus

The specialized compartment within a cell that houses the DNA.

Nutritional and Environmental Therapy (NE)

A clinically-tested nutritional supplement or lifestyle change that has been proven to slow or stop the loss of vision in a retinal degenerative disease.

Nystagmus

Nystagmus is a constant, rapid and involuntary oscillation of the eyes - one of the symptoms that can be experienced by individuals who have a retinal degenerative disease, like Leber congenital amaurosis.

Omega-3 fatty acid

A type of fat that is important for cell function. Also, see DHA.

Optic Nerve

The bundle of nerve cells, or "cable," that transmits signals from the retina to the visual processing center of the brain.

 
<< Start < Prev 1 2 3 4 5 6 7 Next > End >>
Page 4 of 7
US Images

Chapters

Select a state from the dropdown below to view local chapters.


Free Information

Register here to receive free information about your eye condition and research efforts to find treatments and cures.

2012 Annual Report banner
VISIONS 2013 - Side Box banner
VisionWalk banner
Events Calendar